Rowan University

Rowan Digital Works
Faculty Scholarship for the College of Science &
Mathematics

College of Science & Mathematics

8-7-2022

Clinical decision support for intervention reduction in neonatal
patients: A usability assessment
Patrice Dolhonde Tremoulet
Rowan University, tremoulet@rowan.edu

Follow this and additional works at: https://rdw.rowan.edu/csm_facpub
Part of the Medicine and Health Sciences Commons, and the Psychology Commons

Recommended Citation
Tremoulet PD. Clinical decision support for intervention reduction in neonatal patients: A usability
assessment. DIGITAL HEALTH. 2022;8. doi:10.1177/20552076221113696

This Article is brought to you for free and open access by the College of Science & Mathematics at Rowan Digital
Works. It has been accepted for inclusion in Faculty Scholarship for the College of Science & Mathematics by an
authorized administrator of Rowan Digital Works.

Original Research

Clinical decision support for intervention
reduction in neonatal patients: A usability
assessment

Digital Health
Volume 8: 1–12
© The Author(s) 2022
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/20552076221113696
journals.sagepub.com/home/dhj

Patrice D. Tremoulet1

Abstract
Objective: This study investigated how effectively simpliﬁed cognitive walkthroughs, performed independently by four nonclinical researchers, can be used to assess the usability of clinical decision support software. It also helped illuminate the
types of usability issues in clinical decision support software tools that cognitive walkthroughs can identify.
Method: A human factors professor and three research assistants each conducted an independent cognitive walkthrough of a
web-based demonstration version of T3, a physiologic monitoring system featuring a new clinical decision support software
tool called MAnagement Application (MAP). They accessed the demo on personal computers in their homes and used it to
walk through several pre-speciﬁed tasks, answering three standard questions at each step. Then they met to review and
prioritize the ﬁndings.
Results: Evaluators acknowledged several positive features including concise, helpful tooltips and an informative column in
the patient overview which allows users direct (one-click) access to protocol eligibility and compliance criteria.
Recommendations to improve usability include: modify the language to clarify what user actions are possible; visually indicate when eligibility ﬂags are snoozed; and specify which protocol’s data is currently being shown.
Conclusion: Independent, simpliﬁed cognitive walkthroughs can help ensure that clinical decision support software tools will
appropriately support clinicians. Four researchers used this technique to quickly, inexpensively, and effectively assess T3’s
new MAP tool, which suggests positive actions, such as removing a patient from a ventilator. Results indicate that, while
there is room for usability improvements, the MAP tool may help reduce clinician’s cognitive load, facilitating improved
care. The study also conﬁrmed that cognitive walkthroughs identify issues that make clinical decision support software
hard to learn or remember to use.
Keywords
Clinical decision support, protocol management, alert fatigue, cognitive workload, patient monitoring, clinical decision
making, physiologic monitoring
Submission date: 7 November 2021; Acceptance date: 21 June 2022

Introduction
The physiologic monitoring systems used in intensive care
units aggregate real-time data from a variety of different
sources, including pulse oximeters, electrocardiography
devices, infusion pumps, and ventilators.1 Initially, these
systems displayed monitored parameters in real time and
issued alerts whenever data values were outside of preset
thresholds. However, modern systems log patient data,

enabling them to offer clinical decision support capabilities
that leverage recent advances in data science, predictive
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analytics, and clinical informatics.2 For example, several
patient monitoring systems compute early warning scores,
and notify clinicians when scores suggest that a patient’s
condition is worsening.3–5
Although physiologic monitoring systems play an essential role in caring for critically ill patients, they contribute to
alarm fatigue, that is, situations where a large number of
audio signals overwhelm or desensitize users.6,7 Clinical
decision support software (CDSS) that uses early warning
scores or risk indexes to prompt health providers to assess
patients and potentially intervene sooner than they otherwise might, can be beneﬁcial. However, multiple interruptions triggering rapid patient assessments are disruptive of
workﬂow, setting providers up for burnout8,9 which is associated with poor patient safety outcomes.10 In addition,
notiﬁcations based on warning scores or risk indexes can
contribute to alert fatigue: situations where an excess of
visual warnings, ﬂags, or pop-up messages overload and/
or desensitize health providers.11–13 Both alarm fatigue
and alert fatigue negatively impact patient safety.
Healthcare providers that are overwhelmed or desensitized
may delay their responses to, ignore, or dismiss alarms or
alerts that otherwise would have prompted rapid intervention,13–15 leaving patients vulnerable to greater deterioration or more harm than necessary.
On the other hand, the data collected by physiologic
monitoring systems may also be used to detect positive
trends suggesting that a patient’s health is improving.
This ability can be leveraged to create CDSS tools that
provide users with gentle reminders to consider reducing
intensive interventions, rather than obtrusive alerts. One
physiologic monitoring system, called T3, recently
adopted this approach. It features a new component called
MAP that identiﬁes patients who may be good candidates
for clinical protocols, deﬁned as speciﬁc codes of practice
for applying medical interventions. In most acute care settings, a healthcare team works together to determine if a
patient is a good candidate for a clinical trial or decides if
and when to implement a beneﬁcial protocol such as vasoactive weaning (VW) or extubation. This means that at least
one team member must remember and bring the possibility
of eligibility to the team’s attention. CDSS that unobtrusively indicates that a patient is eligible for a protocol can
remove this memory burden from clinicians, allowing
them to focus on other aspects of providing care for their
patients. MAP also tracks and displays compliance data,
enabling clinicians to quickly and easily review physiological data relevant to evaluating the progress of patients
placed on clinical protocols.
CDSS that automatically identiﬁes patients who meet
the criteria for enrolling in a clinical study or starting a
new protocol can reduce clinician workload and
memory demands, but only if clinicians are able to
quickly and easily access a comprehensive,
easy-to-understand summary of relevant patient data;
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otherwise, being presented with ﬂags and reminders
could increase their workload and/or reduce their effectiveness. Similarly, if it is difﬁcult for T3 users to simultaneously access all the data needed to evaluate how well
a patient is tolerating a protocol, clinicians will need
more time than is strictly necessary to assess patients,
reducing efﬁciency and effectiveness. In short, the
usability of T3’s new MAP component will play a signiﬁcant role in determining whether it will facilitate or
inhibit users from effectively caring for patients monitored by T3.
One relatively quick, inexpensive, and convenient method
for assessing usability is the cognitive walkthrough (CW).
This is an analytical technique that entails walking through
the steps needed to perform each of a series of pre-identiﬁed
tasks and answering a small set of questions about how easily
users will be able to perform those tasks. While originally
developed to assess “walk up and use” technologies,16,17
CWs are commonly used to evaluate relatively complex
products,18–20 since most users prefer to interact with
tools to learn how to perform a task rather than read a
manual or follow directions.18 Prior research indicates
that this is true of T3 users; in a study that assessed the
efﬁcacy of training, one participant noted that “using
T3 is the best way to learn to use it”.21 CWs are particularly useful for highlighting aspects of user interfaces that
are intuitive, thus easy to learn and remember, and for
identifying usability issues that may make it hard for
new or infrequent users.22–24
Many variations of CWs have been used to assess the
usability of different types of user interface designs.24–27
There is also a wide variance in terms of the backgrounds
and number of evaluators used. It is valuable for even a
single user interface developer or a team of user interface
designers to conduct CWs,28–32 though some recommend
assembling larger teams that also include project managers
and target users.31,33–35 In fact, one of the signiﬁcant beneﬁts of CW is that it does not require evaluators to be pretrained, nor to have the same domain expertise as an
application’s target users.36,37 In addition, this technique
is relatively simple to perform; however, some researchers have noted that it can be difﬁcult for evaluators to take
into account the real context of use26 and that it does not
provide estimates of frequency or severity of the issues it
uncovers.20 Even with those shortcomings, CWs can be
extremely helpful, by quickly and easily identifying
usability issues early in development lifecycles, when it
is least expensive to address them.24 The study reported
here explores the impact of having a small team of
human factors researchers each independently conduct
a simpliﬁed CW using ﬁrst-person questions, and then
meet to review results, prioritize issues in terms of the
expected impact of resolving them, and generate recommendations. This work addresses several research
questions:
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• Can CWs be performed by four human factors researchers to determine how easily clinicians will be able to use
T3’s new MAP capabilities?
• How effective is it to have evaluators conduct independent CWs rather than a single team-based walkthrough?
• Is it helpful to employ three straightforward questions,
phrased in the ﬁrst person, rather than the four thirdperson questions that are typically used, or the two thirdperson questions developed for streamlined CWs35?
• What usability issues for CDSS are CWs well designed
to identify?

Methods
Rowan University IRB determined that this study does not
qualify as human subjects research and therefore was
exempt from full review.
Four trained evaluators each independently performed a
CW to assess usability of the Beta version of MAP (short
for Management Application). The main steps for conducting a CW are as follows17,30,34,38,39:
1. Create descriptions of the intended users (personas).
2. Decide upon a set of tasks to use to analyze the user
interface.
3. Document the correct sequence(s) of steps needed to
complete each task.
4. Develop instructions for all participants.
5. For each task, go step-by-step, asking the same set of
pre-deﬁned set of questions about each step.
6. Aggregate results and develop a report to share ﬁndings;
ideally issues found should be prioritized in terms of
how much resolution will improve usability.
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accessed a web-based demonstration of T3 version 3.10
with Risk Analytics version 5.3, which displayed de-identiﬁed
historical data from actual patients. This demo version of T3,
which also contained a Beta version of the new MAP tool, was
only available to hospitals who were helping test MAP at the
time of the evaluation. An earlier version of T3 was
deployed34 at other hospitals.

Procedure: CW
All evaluators were instructed to adopt the perspective of a
new user attempting to use the MAP tool to complete a set
of tasks. They were directed to record both all potential
usability problems that they discovered and all ideas for
improvement that they conceived while undertaking the
tasks.
Preparation: Initially, the Psychology professor and
one of the students reviewed training materials, and then
attended a demonstration of the new MAP tool. Next,
the professor developed a list of tasks and descriptions
of the steps required to complete each task. For tasks
that could be completed multiple ways, multiple step
sequences were recorded. After verifying the completion
sequences, the student developed instructions for the
walkthroughs, which included the list of tasks and a set
of three questions that all evaluators answered after
attempting each task.
Analysis: The students were given copies of all the MAP
training materials along with the CW instructions.
Evaluation tasks are listed in the Appendix and post-task
questions are listed in Table 1.
Table 1. Questions used for cognitive walkthroughs (CWs).

Evaluators

Short name

Full question

Three students serving as research assistants in a Human
Factors lab, and the lab director, a Psychology professor,
each independently assessed T3’s MAP tool. All students
had prior experience conducting usability assessments
and had spent at least two semesters working in the
Human Factors lab. All evaluators were familiar with
T3’s user interface. The students had recently participated in a training activity, which entailed reviewing
each screen of a demonstration version of T3 to determine if any usability best practices, called heuristics,
were violated in each screen. The professor had previously conducted heuristic evaluations of two earlier versions of T3, which entailed becoming very comfortable
with its user interface.

Completion

Were you able to complete the task?

Controls

Were the controls clearly visible?

Feedback

Was there feedback to indicate that you
completed (or did not complete)
the task?

Setting
Walkthroughs were conducted using evaluators’ own devices
in their homes during March and April 2021. All evaluators

While attempting to work through each of these tasks,
all evaluators were asked to answer the questions in
Table 1 to help identify positive features and potential
usability concerns.
Once all evaluators had completed their analysis, the
professor aggregated the individual ﬁndings and took
the ﬁrst pass at grouping-related feedback and similar
suggestions for improvement. Then the evaluators met
to review the aggregated results, to ensure that all of
the feedback was accurately reﬂected, and to assign
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priorities to the problems. Priorities were based on the
evaluators’ collective judgement of how much each
problem impacts usability.

Results
For ease of explanation, results are organized based on ﬁve
regions in T3’s user interface that are used to display and/or
interact with the new MAP capabilities. For each region, a
list of positive features is followed by a table listing usability issues. The positive features are aspects of the MAP
functionality that should be retained if the recommended
modiﬁcations are implemented.

Census screen of MAP activity column
Figure 1 shows a screenshot of a part of T3’s census screen.
Positive features:
(a) Clean, easy to read.
(b) Informative tooltips explaining the meanings of icons,
and what numbers represent.
(c) Users can view patient data during current or most recently
completed protocol with a single click.
(d) Users can pull up and review inclusion criteria and
compliance targets for a current/recent protocol with
a single click.

Problem Descriptions and Priorities

Problem Descriptions and Priorities
No tooltip for the three vertical dots (which only appear after
clicking on either Flag or clock/time section of bar). Priority:
Medium-High
Control bar/button is missing tooltip on leftmost icon (ﬂag/
check). Priority: Low
For patients eligible to start a protocol, four clicks are required to
start the protocol or snooze the eligibility ﬂag. Priority: Low

MAP view (MAP tab on individual patient view screen)
Figure 3 shows a screenshot of T3 screen with the MAP tab
selected.
Positive features:
(a) Allows users to quickly review the data for the time the
patient was on the protocol.
(b) Green horizontal lines helpfully graphically overlay
the start and end of protocol trial on large graph
windows.
(c) Shading clearly indicates when parameters are not in
compliance with protocol targets; this is consistent
with the use of shading in other T3 graphical
displays.
(d) Green horizontal lines inside the time navigation slider to
show protocol start/end times relative to the slider is
helpful.

The column header “MAP activity” seems more like application
language than user language. Priority: Medium-High
Not clear what will happen if users click on the leftmost icon in a
MAP activity bar (no tooltip for checks and ﬂags). Priority:
Medium.

Problem Descriptions and Priorities
Not always obvious which protocol trial’s data is being
displayed; it’s possible to be viewing data from a different
protocol trial than the one shown in top center. Priority: High

Patient view of MAP Activity summary (top center)
Figure 2(a) shows the top portion of a patient view screen,
Figure 2(b) shows an enlarged view of the MAP activity
summary bar on a patient view screen, and Figures 2(c),
(d), and (e) show screenshots of pop-up windows that are
displayed after clicking on different regions in the MAP
activity summary bar.
Positive features:
(a) Informative, useful tooltips.
(b) Consistent with display in census view.
(c) Allows users to snooze ﬂags or start eligible patients on
protocols.
(d) Pop-up shown when clicking on the protocol name
(VW/extubation readiness trial, ERT) are clear and
consistent with one another.

Top center MAP activity section can show only one completed
trial but it’s possible to use time navigation controls to show
multiple trials on the display at the same time. Priority: Medium
When a patient has completed multiple trials, it can be hard to
distinguish between start time for one trial and end time for
another. Priority: Low
For a patient who has been eligible for a long time, it is unclear
why a particular interval of time is shown in graphs. Priority: Low

Patient view of MAP icon (checkbox on bottom of
patient view screen)
Figure 4 shows a screenshot of the middle bottom portion of
a T3 patient view screen, which contains several icons,
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Figure 1. Census screen’s new MAP activity column, indicating which patients are currently following protocols, and which ones are eligible. It
also shows the legend for symbols used in this column, which is displayed when users hover the cursor over the information icon.

Figure 2a. Top portion of a patient view screen, showing new “MAP activity summary” (same information as on census page). The
histogram shows one of the T3’s risk indexes, and the graph below it shows heart rate; more physiological data is shown in graphs that are
not included in this screenshot.

Figure 2b. Enlarged view of MAP activity summary.

Figure 2c. Pop-up accessed by clicking ﬁrst on MAP activity
summary bar, then on the three dots that appear after clicking on it.

Figure 2d. Extubation readiness trial (ERT) criteria pop-up accessed
by clicking on the text that states “ERT” in a MAP activity summary.

including one that can be used to bring up pop-up windows
allowing users to see if the patient is eligible for a speciﬁc
protocol and, if so, allowing users to indicate to T3 that they
will be starting patients on a protocol.

Positive features:
(a) Table content is clear and easy to read.
(b) Tooltip that connects this icon to MAP tab and MAP
Activity summary bar top center is helpful.
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directly to MAP tab by allowing the user to review
data relevant to that protocol.
(c) Update button on Start Extubation Readiness pop-up
states that updates require that a patient be eligible or
enrolled in a MAP.
(d) The pop-up table of completed MAPs is clear and
it’s easy to select a row to bring up the MAP tab
display to show data collected during that completed trial.

Figure 2e. Vasoactive weaning (VW) criteria pop-up, accessed by
clicking on “WV” when shown on a MAP activity summary bar
(would show where “ERT” is shown in Figure 2(b) and (c)).

Problem Descriptions and Priorities
MAP pop-up: Not intuitive that user needs to use “click to start
MAP” link to view/adjust Parameter targets. Priority: High

Problem Descriptions and Priorities
Users who want to adjust eligibility criteria for a patient must
remember that the only way they can do this is to ﬁrst click on
this icon. Other things can be done in multiple ways (e.g. start
MAP). Priority: Medium
Check box icon is not intuitive for something named “MAP”.
Priority: Medium–Low

MAP pop-up menus (accessed via MAP icon on
individual patient view screen)
Figure 5(a) shows a screenshot of the pop-up window
that shows whether or not a patient is eligible for speciﬁc clinical protocols and Figure 5(b) shows how the
pop-up changes if the user clicks on a protocol for
which a patient is eligible. Figure 5(c) shows the
pop-up window that is displayed when a user elects to
have an eligible patient start on the VW protocol.
Figure 5(d) shows the pop-up that appears if a patient
has completed one or more clinical protocols and the
user clicks on the bar labeled “Completed MAPs.”
Figure 5(e) shows the pop-up window that is displayed
when a user elects to have an eligible patient start the
ERT.
Positive features:
(a) Clicking on the protocol name (inside initial pop-up,
Figure 5(a)) produces a pop-up summarizing inclusion
criteria and compliance targets.
(b) Clicking “Not Eligible” in a protocol’s control bar in
the initial MAP pop-up brings and takes the user

MAP pop-up: Icon of x in a circle conveys that something is
negative or not allowed which is inconsistent with “click to start
MAP”. Priority: Medium

Recommendations
Based upon the results of the CWs, the team generated
several recommendations, including the following:

1. Ask target users to review the language used throughout MAP, to ensure users clearly understand what
actions are available. Speciﬁcally, consider renaming
“click to start MAP” as “click to review/adjust protocol
parameters”.
2. Allow users to easily view all relevant patient data when
deciding whether or not to start a protocol or evaluating
how well a patient is doing/did while on an active/completed protocol.
3. After snoozing a patient eligibility ﬂag, provide an indicator that the ﬂag has been snoozed (e.g. instead of displaying “No Recent MAP activity,” show “Eligibility
ﬂag snoozed until HH:MM”).
4. When the MAP tab is active, have the MAP activity
summary indicate which is depicted in the graph, a
completed protocol trial, a currently active protocol,
or a recent time interval when eligibility criteria
have been met.
5. Add start date/time to the MAP Activity summary bar.
6. Allow users to snooze eligibility as an option in
the MAP pop-up window (accessed from checkbox
icon).
7. Since clicking the vertical dots in the MAP Activity bar
only yields two options, consider placing icons for these
actions directly on the Activity bar.
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Figure 3. Summary of several physiological parameters during the period that patient was participating in the extubation readiness trial (ERT).

Figure 4. Icon used to access MAP functionality from individual
patient view.

Figure 5b. Change to MAP pop-up shown if user clicks the button
showing patient is eligible to start VW.

Discussion and conclusions

Figure 5a. MAP pop-up accessed by clicking on MAP icon
(checkmark) at bottom of individual patient view screen (see
Figure 4). Based on data captured by the physiologic monitoring
system, this patient is eligible for vasoactive weaning (VW).

Results of independent CWs of T3’s new MAP feature
suggest that novices may ﬁnd some of its features hard to
learn. The evaluators noted that some of the language used
in the MAP tool’s pop-ups and controls seems to be more
application-oriented than user-oriented. They also suggested
that it would be helpful if tooltips and control labels could
help to make it clearer what actions to take when users
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make decisions about patient eligibility. This is consistent
with previously developed guidance that CDSS tools use
language that is familiar to users.40 Moreover, lack of information in the MAP tab tooltip and the fact that the snooze
feature is only available via a three vertical dot display but
the ability to “start MAP” seems to be available through multiple routes, could mean that users need to work harder and/
or take longer to complete basic tasks or to understand how
well patients are doing/did during protocol trials than should
be necessary. These usability issues may lower overall
user satisfaction with the MAP tool, even though it provides
users with relevant and clinically useful information and
capabilities.
On the other hand, despite room for usability improvements, the MAP tool has the potential to signiﬁcantly
beneﬁt both healthcare providers and their patients. With
just a few clicks, users can pull up a customized display
of relevant patient data that helps clinicians quickly understand a patient’s current status and recent history. In the
long term, the MAP tool could contribute to increased efﬁciency, effectiveness, and situational awareness among
clinicians, particularly if recommendations for addressing
existing usability issues developed in this study are
followed.

The evaluators’ results are consistent with feedback provided by clinical Beta testers. This indicates that nonclinical
researchers who use ﬁrst-person evaluation questions while
performing a CW can identify issues that impact how easily
clinicians will be able to use CDSS. It also suggests that it is

Figure 5c. Pop-up window that appears if user clicks on the button
to start VW.

Figure 5e. Pop-up menu that appears when user indicates that
patient will start ERT.

Figure 5d. Another view of the initial MAP pop-up window (to left) accessed by clicking MAP icon (checkmark) and list of completed MAPs (right)
accessed by clicking the button that says “completed MAPs” on initial pop-up. This patient is eligible to start an extubation readiness trial (ERT).
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effective to employ independent walkthroughs followed by
a virtual meeting rather than a collaborative team-based
walkthrough.
These ﬁndings are important for several reasons. First,
although CW is a relatively simple technique that does
not require much training, the target user base for CDSS
tools such as T3—inpatient physicians and nurses—are
extremely busy, which makes it challenging for them to participate in usability evaluations.41 Thus, it is signiﬁcant that
undergraduates and a human factors professor could identify issues that impact CDSS usability for those clinical
experts. Several other researchers have successfully had
nonclinical evaluators–most often software developers or
usability experts—use CWs to assess the usability of
complex health technologies.42–47
Second, having evaluators independently perform CWs
and then meet to review results and generate recommendations can be more efﬁcient than having a group collaboratively perform a CW. At the time this study was
performed, large face-to-face meetings were rare due to
COVID-19 restrictions. Evaluators in this study were able
to perform independent walkthroughs in their homes, and
the review meeting was conducted via videoconferencing
software. Even without social distancing restrictions,
trying to schedule a time for a diverse team to meet to walkthrough a user interface can be challenging, so it is notable
that independent walkthroughs can be productive.
Third, instructing evaluators to adopt the perspective of a
new user and then directing them to answer ﬁrst-person
questions based on their experience, rather than answering
questions about what clinical users would likely experience,
helps make CWs more straightforward for novice evaluators. (One criticism of CW is that it can be difﬁcult for participants to truly represent the perspective of target users.26)
This modiﬁcation was especially advantageous in the
context of this study where students who had not previously
participated in a CW were tasked to perform independent
walkthroughs.
In general, CWs help to identify features of interfaces
that inﬂuence how easily users will be able to learn, and
remember, how to use applications.18,24,28 Hence, this technique is particularly helpful in identifying those features in
CDSS user interfaces. In addition, CWs are well suited to
assess the comprehensibility and utility of contextual information that is intended to support users’ decision making.
In fact, several of the results of this study—including
both positive and negative ﬁndings, could be generalized
into guidelines for producing useful, usable CDSS tools.
For example, the evaluators indicated that one-click
access to relevant physiological data about a patient who
has been identiﬁed as a candidate for a clinical protocol,
and displaying eligibility criteria for a protocol via a mouseover, are both positive features of MAP. These results
suggest guidance that CDSS tools enable the users to
quickly and easily access relevant contextual information
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that helps explain why a particular action is (or is not) suggested or why a particular alert/alarm has been ﬁred. This
aligns with prior research suggesting that CDSS recommendations be accompanied by simple explanations of why
they are recommended,48,49 and that CDSS should be a
“clinical partner”.50 In addition, the results of this study
suggest that it is beneﬁcial both for busy clinicians to be
able to defer or “snooze” notiﬁcations that patient health is
improving, so that intervention reductions can be considered
later, and for there to be a visual indicator that a notiﬁcation
has been deferred. This is consistent with previously developed
guidance that CDSS should ﬁt into users existing workﬂows,48,51,52 and that it should be “a team player”.50
Meanwhile, evaluators’ judgement that MAP requires
users to perform too many clicks to indicate that a patient
will be starting on a protocol can be generalized as “make
it as easy as possible to implement recommendations provided
by CDSS tools”, which is consistent with other researchers’
guidance to minimize numbers of clicks/screens48,53 and to
make it easy to follow recommended actions.48,51,52 Other
results can be generalized as “consistently allow users multiple
ways to perform the same action”. This is aligned with general
guidance to aim for consistency in any user interface.53 In
summary, the candidates for general guidelines for creating
useful, usable CDSS tools suggested by this study complement and extend existing literature that contains guidelines
for creating successful CDSS tools.
While this study effectively identiﬁed several positive
features of the new MAP tool and produced recommendations for changes that could improve its usability, the
study has some limitations. Rather than a diverse team
that includes intended users, evaluators are all researchers
afﬁliated with the same human factors lab, and most were
undergraduate students. Having at least one clinical expert
would have strengthened the study—though domain
expertise is not required for CWs.28 Moreover, the students
had different educational backgrounds: one was a psychology major heading to medical school, one was an engineering major headed to a clinical psychology graduate
program, and the third one was a computer science major,
who had over 2 years of experience working in healthcare
as an x-ray technician. In addition, the effort was led by a
human factors expert with over two decades of experience
and all students had prior experience evaluating usability,
including participating in a heuristic evaluation of an
earlier version of T3.54
That said, students working in a human factors lab are
adept at adopting the perspective of target users since
understanding users’ needs is central to their research. As
a result, these students may have an easier time putting
themselves into the shoes of clinical experts for the
purpose of a usability assessment than other potential CW
participants. This suggests that other CW participants
might still have had difﬁculty taking the perspective of
users even when given ﬁrst-person questions. Despite
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these limitations, the positive features, issues, and recommendations generated in this study can be applied to
improve the usability of T3’s MAP functionality, which
in turn can result in improved care for patients in hospitals
that use T3. In particular, T3’s MAP tool can beneﬁt
patients whose health is improving by gently prompting
clinicians to consider reducing intensive interventions and
making it easy for those clinicians to access relevant data.
Moreover, several of the results of this study suggest possible guidelines for developing useful, easy-to-use CDSS
tools, although additional research is needed to determine
how broadly applicable these potential guidelines are.
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Appendix. Tasks used for MAP cognitive walkthroughs (CWs).
Task name

Task description

Enroll patient in vasoactive weaning (VW)

Indicate to T3 that a patient is starting VW protocol.

Start screening patient for extubation readiness Indicate that a patient is potentially a candidate for an ERT so T3 includes this patient
trial (ERT)
in eligibility scans.
Snooze eligibility ﬂag(s)

Temporarily stop displaying patient eligibility notiﬁcation ﬂag (both ERT and VW ﬂags)

View/edit compliance and eligibility criteria

Conﬁrm/adjust inclusion and compliance criteria for a single patient

View enrolled patient’s progress

Check how patient is doing on an ongoing protocol (both ERT and VW—access new
MAP view)

Review all data from a patient who completed a Review how a patient did while on a completed protocol (both ERT and VW)
protocol
Check trial dates

Find start and end times for a completed patient trial

View compliance data for a completed patient

Determine which compliance criteria, if any, were not fully met during a completed
trial

View compliance data for an enrolled patient

Determine which, if any, compliance criteria have not been fully met by a patient
currently under a protocol

Find eligible patients

Identify all patients currently eligible to start a protocol

Tremoulet

11

References
1. ECRI. Physiologic monitoring systems. Health Devices 2000;
29: 153–184.
2. ECRI. Evaluation background: ICU physiologic monitoring
systems. Health Devices 2020; 29: 153–155
3. Arney D, Zhang Y, Goldman JM, et al. Implementing
Real-Time Clinical Decision Support Applications on
OpenICE: A Case Study Using the National Early Warning
System Algorithm. In: 2019 IEEE/ACM International
Conference on Connected Health: Applications, Systems and
Engineering Technologies (CHASE) 2019, pp.35–40: IEEE.
4. Weenk M, Koeneman M, van de Belt TH, et al. Wireless and
continuous monitoring of vital signs in patients at the general
ward. Resuscitation 2019; 136: 47–53.
5. Blankush JM, Freeman R, McIlvaine J, et al. Implementation
of a novel postoperative monitoring system using automated
modiﬁed early warning scores (MEWS) incorporating
end-tidal capnography. J Clin Monit Comput 2017; 31:
1081–1092.
6. Sendelbach S and Funk M. Alarm fatigue: A patient safety
concern. AACN Adv Crit Care 2013; 24: 378–386.
7. Bell L. Monitor alarm fatigue. Am J Crit Care 2010; 19:
38–38.
8. Co Z, Holmgren AJ, Classen DC, et al. The tradeoffs between
safety and alert fatigue: Data from a national evaluation of
hospital medication-related clinical decision support. J Am
Med Inform Assoc 2020; 27: 1252–1258.
9. Collier R. Rethinking EHR interfaces to reduce click fatigue
and physician burnout. Can Med Assoc 2018; 190(33):
E994–E995
10. Hall LH, Johnson J, Watt I, et al. Healthcare staff wellbeing,
burnout, and patient safety: A systematic review. PloS one
2016; 11: e0159015.
11. Beasley BW. Commentary: How ‘alert fatigue’ truly exhausts
US. Physician Leadersh J 2018; 5: 60–62.
12. Cash JJ. Alert fatigue. Am J Health-Syst Pharm 2009; 66:
2098–2101.
13. Ancker JS, Edwards A, Nosal S, et al. Effects of workload, work
complexity, and repeated alerts on alert fatigue in a clinical decision support system. BMC Med Inform Decis Mak 2017; 17: 1–9.
14. Baker K and Rodger J. Assessing causes of alarm fatigue in
long-term acute care and its impact on identifying clinical
changes in patient conditions. Informatics in Medicine
Unlocked 2020; 18: 100300.
15. Evans G, Steele B and Setliff E. 1371: Managing physiologic
alarms to reduce alarm fatigue. Crit Care Med 2020; 48: 662.
16. Lewis C, Polson PG, Wharton C, et al. Testing a walkthrough
methodology for theory-based design of walk-up-and-use
interfaces. Proc SIGCHI Conf Hum Fact Comp Syst 1990;
1: 235–242.
17. Wharton C, Rieman J, Lewis C, et al. The cognitive walkthrough: a practitioner’s guide. Usability inspection
methods. New York: John Wiley, 1994, pp. 105–140.
18. Wharton C, Bradford J, Jeffries R, et al. Applying cognitive
walkthroughs to more complex user interfaces: Experiences,
issues, and recommendations. Proc SIGCHI Conf Hum Fact
Comp Syst 1992; 1: 381–388.
19. Lewis C and Wharton C. Cognitive walkthroughs. In
Handbook of Human-Computer Interaction, 2nd ed. Edited

20.
21.

22.

23.

24.

25.

26.

27.

28.

29.

30.

31.
32.
33.

34.

35.

36.

37.

by Helander M, Landauer TK and Prabhu P. Elsevier, 1997,
pp. 717–732.
Association UEP. Cognitive Walkthrough., https://www.
usabilitybok.org/cognitive-walkthrough 2012.
Tremoulet P, Clark K, McManus M, et al. IVCO2 `training
effectiveness study. Proc Int Symp Hum Fact Ergon Heal
Car 2020; 1: 45–49.
Polson PG, Lewis C, Rieman J, et al. Cognitive walkthroughs:
A method for theory-based evaluation of user interfaces. Int J
Man Mach Stud 1992; 36: 741–773.
Khajouei R, Zahiri Esfahani M and Jahani Y. Comparison of
heuristic and cognitive walkthrough usability evaluation
methods for evaluating health information systems. J Am
Med Inform Assoc 2017; 24: e55–e60.
Bligård L-O and Osvalder A-L. Enhanced cognitive walkthrough: Development of the cognitive walkthrough method
to better predict, identify, and present usability problems.
Advances in Human-Computer Interaction 2013; 1–17.
Mahatody T, Sagar M and Kolski C. State of the art on the cognitive walkthrough method, its variants and evolutions. Intl
Journal of Human–Computer Interaction 2010; 26: 741–785.
Mahatody T, Sagar M and Kolski C. Cognitive walkthrough for
HCI evaluation: Basic concepts, evolutions and variants,
research issues. Proceedings EAM 2007 European Annual
Conference on Human-Decision Making and Manual Control,
Technical University of Danemark, Lyngby 2007; 1: 1–12.
Dieter M and Tkacz N. The patterning of ﬁnance/security: A
designerly walkthrough of challenger banking apps.
Computational Culture 2020; 7: 1–39.
Rieman J, Franzke M and Redmiles D. Usability evaluation
with the cognitive walkthrough. In: Conference companion
on Human factors in computing systems 1995, pp. 387–388.
Samrgandi N. User interface design & evaluation of mobile
applications. International Journal of Computer Science &
Network Security 2021; 21: 55–63.
Woodmas R. The Cognitive Walkthrough: A Low-Cost
Usability Testing Method and Empathy Training Tool,
https://xd.adobe.com/ideas/process/user-testing/cognitivewalkthrough-improve-ux/ (2020, accessed May 28 2022).
Lewis C and Rieman J. Task-centered user interface design. A
Practical introduction 1993.
May J and Barnard P. The case for supportive evaluation
during design. Interact Comput 1995; 7: 115–143.
Grigoreanu V and Mohanna M. Informal cognitive walkthroughs (icw) paring down and pairing up for an agile
world. Proc SIGCHI Conf Hum Fact Comp Syst 2013; 1:
3093–3096.
Salazar K. Evaluate Interface Learnability with Cognitive
Walkthroughs, https://www.nngroup.com/articles/cognitivewalkthroughs/ (2022, accessed May 28 2022).
Spencer R. The streamlined cognitive walkthrough method,
working around social constraints encountered in a software
development company. Proc SIGCHI Conf on Hum Fact
Comp Syst 2000; 1: 353–359.
Jaspers MW. A comparison of usability methods for testing
interactive health technologies: Methodological aspects and
empirical evidence. Int J Med Inf 2009; 78: 340–353.
Foundation ID. How to conduct a cognitive walkthrough,
https://www.interaction-design.org/literature/article/how-toconduct-a-cognitive-walkthrough 2021.

12
38. Nielsen J. Usability inspection methods. In: Conference companion on Human factors in computing systems 1994, pp.413–414.
39. Nielsen J. Usability engineering. San Diego, CA: Elsevier, 1994.
40. Miller K, Mosby D, Capan M, et al. Interface, information,
interaction: A narrative review of design and functional
requirements for clinical decision support. J Am Med Inform
Assoc 2018; 25: 585–592.
41. Tremoulet P, Krishnan R, Karavite D, et al. A heuristic evaluation to assess use of after visit summaries for supporting continuity of care. Appl Clin Inform 2018; 9: 714–724.
42. Liu Y, Osvalder A-L and Dahlman S. Exploring user background settings in cognitive walkthrough evaluation of
medical prototype interfaces: A case study. Int J Ind Ergon
2005; 35: 379–390.
43. Farzandipour M, Nabovati E, Tadayon H, et al. Usability evaluation of a nursing information system by applying cognitive
walkthrough method. Int J Med Inf 2021; 152: 104459.
44. Ghalibaf AK, Jangi M, Habibi MRM, et al. Usability evaluation
of obstetrics and gynecology information system using cognitive
walkthrough method. Electron Physician 2018; 10: 6682.
45. Peute LW and Jaspers MM. Usability evaluation of a laboratory
order entry system: Cognitive walkthrough and think aloud
combined. Stud Health Technol Inform 2005; 116: 599–604.
46. Liljegren E and Osvalder A-L. Cognitive engineering
methods as usability evaluation tools for medical equipment.
Int J Ind Ergon 2004; 34: 49–62.
47. Arshad F, Nnamoko N, Wilson J, et al. Improving healthcare
system usability without real users: A semi-parallel design

DIGITAL HEALTH

48.

49.

50.

51.

52.

53.

54.

approach. International Journal of Healthcare Information
Systems and Informatics (IJHISI 2015; 10: 67–81.
Lee S. Features of computerized clinical decision support
systems supportive of nursing practice: A literature review.
CIN: Computers, Informatics, Nursing 2013; 31: 477–495.
Chase JG, Andreassen S, Jensen K, et al. Impact of human
factors on clinical protocol performance: a proposed
assessment framework and case examples. J Diabetes Sci
Technol 2008 May; 2(3): 409–416. doi:10.1177/
193229680800200310.
Pelayo S, Marcilly R, Bernonville S, Leroy N, BeuscartZephir MC. Human factors based recommendations for the
design of medication related clinical decision support systems
(CDSS). Stud Health Technol Inform 2011; 169: 412–416.
Wright M-O and Robicsek A. Clinical decision support
systems and infection prevention: To know is not enough.
Am J Infect Control 2015; 43: 554–558.
Kawamoto K, Houlihan CA, Balas EA, et al. Improving clinical practice using clinical decision support systems: A systematic review of trials to identify features critical to
success. Br Med J 2005; 330: 765.
Tsopra R, Jais J-P, Venot A, et al. Comparison of two kinds of
interface, based on guided navigation or usability principles,
for improving the adoption of computerized decision
support systems: Application to the prescription of antibiotics.
J Am Med Inform Assoc 2014; 21: e107–e116.
Meyeroff E and Tremoulet P. Etiometry’s T3 heuristic evaluation. Proc Int Symp Hum Fact Ergon Heal Car 2021; 1: 37–41.

